
TOTAL VIEWS: 1646
The study of functional changes in the muscular system under physical exertion remains a pressing issue in modern physiology and sports science. Advances in modern molecular genetic research methods have significantly enhanced our understanding in this field. However, the overemphasis on molecular aspects has somewhat overshadowed the systemic approach to analyzing muscle function during physical activity and related processes. This has resulted in an overwhelming amount of data requiring comprehensive analysis and systematization through an interdisciplinary approach. While numerous studies have addressed systemic analysis of muscle function and fatigue, most focus on examining classical fatigue markers. These markers, however, fail to fully explain the complex processes occurring in muscles during physical exertion. Therefore, in preparing this article, we aimed not only to systematize accumulated data on the subject. Our analysis revealed non-canonical roles of key players including calpains, as well as the nervous and immune systems. These findings may prove crucial for better understanding muscular mechanisms during exercise. A thorough comprehension of these mechanisms could enable better control of bodily states during physical exertion, enhancing performance while mitigating negative effects. The materials presented here may serve as a foundation for future experiments targeting critical control points and developing novel monitoring methods for muscular processes at varying activity levels.
Physical load; overload; fatigue; nitric oxide; calpains; calcium; myokines; inflammatory
[1] Cinelli MA, Do HT, Miley GP, Silverman RB. Inducible nitric oxide synthase: Regulation, structure, and inhibition. Med Res Rev. 2020;40(1):158-89. doi:10.1002/med.21599
[2] Muskat JC, Babbs CF, Goergen CJ, Rayz VL. Transport of nitrite from large arteries modulates regional blood flow during stress and exercise. Front Cardiovasc Med. 2023;10:1146717. doi:10.3389/fcvm.2023.1146717
[3] Tarkin JM, Kaski JC. Nicorandil and Long-acting Nitrates: Vasodilator Therapies for the Management of Chronic Stable Angina Pectoris. Eur Cardiol. 2018;13(1):23-28. doi:10.15420/ecr.2018.9.2
[4] Lee-Young RS, Ayala JE, Hunley CF, et al. Endothelial nitric oxide synthase is central to skeletal muscle metabolic regulation and enzymatic signaling during exercise in vivo. Am J Physiol Regul Integr Comp Physiol. 2010;298(5):R1399-408. doi:10.1152/ajpregu.00004.2010
[5] Rassaf T, Flögel U, Drexhage C, et al. Nitrite reductase function of deoxymyoglobin: oxygen sensor and regulator of cardiac energetics and function. Circ Res. 2007;100(12):1749-54. doi:10.1161/CIRCRESAHA.107.152488
[6] Ghafourifar P, Cadenas E. Mitochondrial nitric oxide synthase. Trends Pharmacol Sci. 2005;26(4):190-5. doi:10.1016/j.tips.2005.02.005
[7] Cleeter MW, Cooper JM, Darley-Usmar VM, et al. Reversible inhibition of cytochrome c oxidase by nitric oxide. FEBS Lett. 1994;345(1):50-4. doi:10.1016/0014-5793(94)00424-2
[8] Taylor CT, Moncada S. Nitric oxide, cytochrome C oxidase, and the cellular response to hypoxia. Arterioscler Thromb Vasc Biol. 2010;30(4):643-7. doi:10.1161/ATVBAHA.108.181628
[9] Poderoso JJ, Carreras MC, Lisdero C, et al. Nitric oxide inhibits electron transfer and increases superoxide radical production in rat heart mitochondria. Arch Biochem Biophys. 1996;328(1):85-92. doi:10.1006/abbi.1996.0146
[10] Boveris A, Costa LE, Poderoso JJ, et al. Regulation of mitochondrial respiration by oxygen and nitric oxide. Ann N Y Acad Sci. 2000;899:121-35. doi:10.1111/j.1749-6632.2000.tb06181.x
[11] Cadenas E. Mitochondrial free radical production and cell signaling. Mol Aspects Med. 2004;25(1-2):17-26. doi:10.1016/j.mam.2004.02.005
[12] Liu JZ, Dai TH, Sahgal V, et al. Nonlinear cortical modulation of muscle fatigue: a functional MRI study. Brain Res. 2002;957(2):320-9. doi:10.1016/s0006-8993(02)03665-x
[13] Klass M, Lévénez M, Enoka RM, Duchateau J. Spinal mechanisms contribute to differences in the time to failure of submaximal fatiguing contractions. J Neurophysiol. 2008;99(3):1096-104. doi:10.1152/jn.01252.2007
[14] Martin PG, Weerakkody N, Gandevia SC, Taylor JL. Group III and IV muscle afferents differentially affect the motor cortex and motoneurones in humans. J Physiol. 2008;586(5):1277-89. doi:10.1113/jphysiol.2007.140426
[15] Brüne B, Lapetina EG. Activation of a cytosolic ADP-ribosyltransferase by nitric oxide-generating agents. J Biol Chem. 1989;264(15):8455-8. PMID:2542278
[16] Ghanta M, Panchanathan E, Lakkakula BVKS, Narayanaswamy A. Retrospection on the Role of Soluble Guanylate Cyclase in Parkinson’s Disease. J Pharmacol Pharmacother. 2017;8(3):87-91. doi:10.4103/jpp.JPP_45_17
[17] Kuo IY, Ehrlich BE. Signaling in muscle contraction. Cold Spring Harb Perspect Biol. 2015;7(2):a006023. doi:10.1101/cshperspect.a006023
[18] Tengan CH, Rodrigues GS, Godinho RO. Nitric oxide in skeletal muscle: role on mitochondrial biogenesis and function. Int J Mol Sci. 2012;13(12):17160-84. doi:10.3390/ijms131217160
[19] Erusalimsky JD, Moncada S. Nitric oxide and mitochondrial signaling. Arterioscler Thromb Vasc Biol. 2007;27(12):2524-31. doi:10.1161/ATVBAHA.107.151167
[20] Chesnokova NP, Ponukalina EV, Bizenkova MN. Molecular and cellular mechanisms of induction of free radical oxidation in pathological conditions. Mod Probl Sci Educ. 2006;6:21-6. Russian.
[21] Indo HP, Yen HC, Nakanishi I, et al. A mitochondrial superoxide theory for oxidative stress diseases and aging. J Clin Biochem Nutr. 2015;56(1):1-7. doi:10.3164/jcbn.14-42
[22] Malakhov VA. The problem of nitrogen oxide in neurology. Sumi; 2009. Russian.
[23] Lobachev VL, Rudakov ES. The chemistry of peroxynitrite. Russ Chem Rev. 2006;75(5):375-96. doi:10.1070/RC2006v075n05ABEH001212
[24] Starodubtseva MN. The dual role of peroxynitrite in the body. Probl Health Ecol. 2004;1:35-41. Russian.
[25] Ahmad R, Rasheed Z, Ahsan H. Biochemical and cellular toxicology of peroxynitrite. Immunopharmacol Immunotoxicol. 2009;31(3):388-96. doi:10.1080/08923970802709197
[26] Davignon J, Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation. 2004;109(3):27-32. doi:10.1161/01.cir.0000131515.03336.f8
[27] Boccini F, Herold S. Mechanistic studies of the oxidation of oxyhemoglobin by peroxynitrite. Biochemistry. 2004;43:16393-404. doi:10.1021/bi0482250
[28] Romero N, Radi R, Linares E, et al. Reaction of human hemoglobin with peroxynitrite. J Biol Chem. 2003;278(45):44049-57. doi:10.1074/jbc.M307620200
[29] Pinton P, Giorgi C, Siviero R, et al. Calcium and apoptosis: ER-mitochondria Ca2+ transfer in the control of apoptosis. Oncogene. 2008;27(50):6407-18. doi:10.1038/onc.2008.308
[30] Hyatt HW, Powers SK. The Role of Calpains in Skeletal Muscle Remodeling with Exercise. Int J Sports Med. 2020;41(14):994-1008. doi:10.1055/a-1199-7662
[31] Ono Y, Saido TC, Sorimachi H. Calpain research for drug discovery. Nat Rev Drug Discov. 2016;15:854-76. doi:10.1038/nrd.2016.212
[32] Murphy RM. Calpains, skeletal muscle function and exercise. Clin Exp Pharmacol Physiol. 2010;37:385-91. doi:10.1111/j.1440-1681.2009.05310.x
[33] Edmunds T, Nagainis PA, Sathe SK, et al. Comparison of the autolyzed and unautolyzed forms of mu- and m-calpain. Biochim Biophys Acta. 1991;1077(2):197-208. doi:10.1016/0167-4838(91)90059-9
[34] Tan Y, Wu C, De Veyra T, et al. Ubiquitous calpains promote both apoptosis and survival signals. J Biol Chem. 2006;281:17689-98. doi:10.1074/jbc.M601978200
[35] Yuasa T, Amo-Shiinoki K, Ishikura S. Sequential cleavage of insulin receptor by calpain 2 and gamma-secretase. Diabetologia. 2016;59:2711-21. doi:10.1007/s00125-016-4102-5
[36] Goll DE, Thompson VF, Li H. The calpain system. Physiol Rev. 2003;83:731-801. doi:10.1152/physrev.00029.2002
[37] Campbell RL, Davies PL. Structure-function relationships in calpains. Biochem J. 2012;447:335-51. doi:10.1042/BJ20120921
[38] Kramerova I, Kudryashova E, Wu B. Novel role of calpain-3 in the triad-associated protein complex. Hum Mol Genet. 2008;17:3271-80. doi:10.1093/hmg/ddn223
[39] Kramerova I, Kudryashova E, Ermolova N. Impaired calcium calmodulin kinase signaling in the absence of calpain 3. Hum Mol Genet. 2012;21:3193-204. doi:10.1093/hmg/dds144
[40] Gailly P, De Backer F, Van Schoor M, Gillis JM. In situ measurements of calpain activity in isolated muscle fibres. J Physiol. 2007;582(Pt3):1261-75. doi:10.1113/jphysiol.2007.132191
[41] Raastad T, Owe SG, Paulsen G. Changes in calpain activity after eccentric exercise. Med Sci Sports Exerc. 2010;42:86-95. doi:10.1249/MSS.0b013e3181ac7afa
[42] Lowell BB, Ruderman NB, Goodman MN. Evidence that lysosomes are not involved in the degradation of myofibrillar proteins. Biochem J. 1986;234(1):237-40. doi:10.1042/bj2340237
[43] Solomon V, Goldberg AL. Importance of the ATP-ubiquitin-proteasome pathway. J Biol Chem. 1996;271(43):26690-7. doi:10.1074/jbc.271.43.26690
[44] Averna M, Stifanese R, De Tullio R, et al. Proteolytic degradation of nitric oxide synthase isoforms by calpain. FEBS J. 2007;274(23):6116-27. doi:10.1111/j.1742-4658.2007.06133.x
[45] Bellocq A, Doublier S, Suberville S, et al. Somatostatin increases glucocorticoid binding and signaling in macrophages. J Biol Chem. 1999;274(52):36891-6. doi:10.1074/jbc.274.52.36891
[46] Corona BT, Balog EM, Doyle JA. Junctophilin damage contributes to early strength deficits. Am J Physiol Cell Physiol. 2010;298:C365-76. doi:10.1152/ajpcell.00365.2009
[47] Franzini-Armstrong C, Jorgensen AO. Structure and development of E-C coupling units in skeletal muscle. Annu Rev Physiol. 1994;56:509-34. doi:10.1146/annurev.ph.56.030194.002453
[48] Kanzaki K, Watanabe D, Kuratani M, et al. Role of calpain in eccentric contraction-induced proteolysis. J Appl Physiol (1985). 2017;122(2):396-405. doi:10.1152/japplphysiol.00270.2016
[49] Ito K, Komazaki S, Sasamoto K, et al. Deficiency of triad junction and contraction in mutant skeletal muscle lacking junctophilin type 1. J Cell Biol. 2001;154(5):1059-67. doi:10.1083/jcb.200105040
[50] Goll DE, Neti G, Mares SW, Thompson VF. Myofibrillar protein turnover. J Anim Sci. 2008;86(14Suppl):E19-35. doi:10.2527/jas.2007-0395
[51] Lek A, Evesson FJ, Lemckert FA, et al. Calpains, cleaved mini-dysferlinC72, and L-type channels underpin calcium-dependent muscle membrane repair. J Neurosci. 2013;33(12):5085-94. doi:10.1523/JNEUROSCI.3560-12.2013
[52] Belcastro AN. Skeletal muscle calcium-activated neutral protease with exercise. J Appl Physiol (1985). 1993;74(3):1381-6. doi:10.1152/jappl.1993.74.3.1381
[53] Roche JA, Lovering RM, Bloch RJ. Impaired recovery of dysferlin-null skeletal muscle after contraction-induced injury. Neuroreport. 2008;19:1579-84. doi:10.1097/WNR.0b013e328311ca35
[54] Vermaelen M, Sirvent P, Raynaud F, et al. Differential localization of autolyzed calpains 1 and 2 in slow and fast skeletal muscles. Am J Physiol Cell Physiol. 2007;292(5):C1723-31. doi:10.1152/ajpcell.00398.2006
[55] Fougerousse F, Bullen P, Herasse M, et al. Human-mouse differences in the embryonic expression patterns of developmental control genes. Hum Mol Genet. 2000;9(2):165-73. doi:10.1093/hmg/9.2.165
[56] Smith IC, Collao N, Herzog W. The effects of inorganic phosphate on contractile function of slow skeletal muscle fibres. Biochem Biophys Res Commun. 2020;533(4):818-23. doi:10.1016/j.bbrc.2020.09.092
[57] Gonzalez-Serratos H, Somlyo AV, McClellan G, et al. Composition of vacuoles and sarcoplasmic reticulum in fatigued muscle. Proc Natl Acad Sci USA. 1978;75(3):1329-33. doi:10.1073/pnas.75.3.1329
[58] Kemp GJ, Meyerspeer M, Moser E. Absolute quantification of phosphorus metabolite concentrations in human muscle. NMR Biomed. 2007;20(6):555-65. doi:10.1002/nbm.1192
[59] Fitts RH. The cross-bridge cycle and skeletal muscle fatigue. J Appl Physiol (1985). 2008;104(2):551-8. doi:10.1152/japplphysiol.01200.2007
[60] Allen DG, Westerblad H. Role of phosphate and calcium stores in muscle fatigue. J Physiol. 2001;536(Pt3):657-65. doi:10.1111/j.1469-7793.2001.t01-1-00657.x
[61] Allen DG, Trajanovska S. The multiple roles of phosphate in muscle fatigue. Front Physiol. 2012;3:463. doi:10.3389/fphys.2012.00463
[62] Dutka TL, Cole L, Lamb GD. Calcium phosphate precipitation in the sarcoplasmic reticulum. Am J Physiol Cell Physiol. 2005;289(6):C1502-12. doi:10.1152/ajpcell.00273.2005
[63] Laver DR, Lenz GK, Dulhunty AF. Phosphate ion channels in sarcoplasmic reticulum. J Physiol. 2001;535(Pt3):715-28. doi:10.1111/j.1469-7793.2001.t01-1-00715.x
[64] DeBold EP, Romatowski J, Fitts RH. The depressive effect of Pi on the force-pCa relationship. Am J Physiol Cell Physiol. 2006;290(4):C1041-50. doi:10.1152/ajpcell.00342.2005
[65] Romer LM, Haverkamp HC, Amann M, et al. Effect of acute severe hypoxia on peripheral fatigue. Am J Physiol Regul Integr Comp Physiol. 2007;292(1):R598-606. doi:10.1152/ajpregu.00269.2006
[66] Palmer S, Kentish JC. The role of troponin C in modulating the Ca2+ sensitivity. J Physiol. 1994;480(Pt1):45-60. doi:10.1113/jphysiol.1994.sp020339
[67] Knuth ST, Dave H, Peters JR, Fitts RH. Low cell pH depresses peak power in rat skeletal muscle fibres. J Physiol. 2006;575(Pt3):887-99. doi:10.1113/jphysiol.2006.106732
[68] Karatzaferi C, Franks-Skiba K, Cooke R. Inhibition of shortening velocity of skinned skeletal muscle fibers. Am J Physiol Regul Integr Comp Physiol. 2008;294(3):R948-55. doi:10.1152/ajpregu.00541.2007
[69] Nelson CR, DeBold EP, Fitts RH. Phosphate and acidosis act synergistically to depress peak power. Am J Physiol Cell Physiol. 2014;307(10):C939-50. doi:10.1152/ajpcell.00206.2014
[70] Danial NN, Korsmeyer SJ. Cell death: critical control points. Cell. 2004;116(2):205-19. doi:10.1016/s0092-8674(04)00046-7
[71] Delbridge AR, Grabow S, Strasser A, Vaux DL. Thirty years of BCL-2. Nat Rev Cancer. 2016;16(2):99-109. doi:10.1038/nrc.2015.17
[72] Popgeorgiev N, Jabbour L, Gillet G. Subcellular Localization and Dynamics of the Bcl-2 Family. Front Cell Dev Biol. 2018;6:13. doi:10.3389/fcell.2018.00013
[73] Tews DS, Goebel HH. DNA fragmentation and BCL-2 expression in infantile spinal muscular atrophy. Neuromuscul Disord. 1996;6(4):265-73. doi:10.1016/0960-8966(96)00018-1
[74] Tews DS, Goebel HH. Apoptosis-related proteins in skeletal muscle fibers of spinal muscular atrophy. J Neuropathol Exp Neurol. 1997;56(2):150-6. doi:10.1097/00005072-199702000-00005
[75] Parker GC, Li X, Anguelov RA, et al. Survival motor neuron protein regulates apoptosis. Neurotox Res. 2008;13(1):39-48. doi:10.1007/BF03033366
[76] Aouacheria A, Arnaud E, Venet S, et al. Nrh, a human homologue of Nr-13 associates with Bcl-Xs. Oncogene. 2001;20(41):5846-55. doi:10.1038/sj.onc.1204740
[77] White C, Li C, Yang J, et al. The endoplasmic reticulum gateway to apoptosis. Nat Cell Biol. 2005;7(10):1021-8. doi:10.1038/ncb1302
[78] Schulman JJ, Wright FA, Kaufmann T, Wojcikiewicz RJH. The Bcl-2 protein family member Bok binds to inositol 1,4,5-trisphosphate receptors. J Biol Chem. 2013;288(35):25340-9. doi:10.1074/jbc.M113.496570
[79] Germain M, Mathai JP, Shore GC. BH-3-only BIK functions at the endoplasmic reticulum. J Biol Chem. 2002;277(20):18053-60. doi:10.1074/jbc.M201235200
[80] Baffy G, Miyashita T, Williamson JR, Reed JC. Apoptosis induced by withdrawal of interleukin-3. J Biol Chem. 1993;268(9):6511-9. doi:10.1016/S0021-9258(18)53291-2
[81] Pinton P, Ferrari D, Magalhães P, et al. Reduced loading of intracellular Ca(2+) stores in Bcl-2-overexpressing cells. J Cell Biol. 2000;148(5):857-62. doi:10.1083/jcb.148.5.857
[82] Pinton P, Rimessi A, Romagnoli A, et al. Biosensors for the detection of calcium and pH. Methods Cell Biol. 2007;80:297-325. doi:10.1016/S0091-679X(06)80015-4
[83] Palmer AE, Jin C, Reed JC, Tsien RY. Bcl-2-mediated alterations in endoplasmic reticulum Ca2+. Proc Natl Acad Sci USA. 2004;101(50):17404-9. doi:10.1073/pnas.0408030101
[84] Bonneau B, Prudent J, Popgeorgiev N, Gillet G. Non-apoptotic roles of Bcl-2 family. Biochim Biophys Acta. 2013;1833(7):1755-65. doi:10.1016/j.bbamcr.2013.01.021
[85] Gautam M, Benson CJ. Acid-sensing ion channels in mouse skeletal muscle afferents. FASEB J. 2013;27(2):793-802. doi:10.1096/fj.12-220400
[86] Jankowski MP, Rau KK, Ekmann KM, et al. Comprehensive phenotyping of group III and IV muscle afferents in mouse. J Neurophysiol. 2013;109(9):2374-81. doi:10.1152/jn.01067.2012
[87] Light AR, Hughen RW, Zhang J, et al. Dorsal root ganglion neurons innervating skeletal muscle respond to physiological combinations of protons, ATP, and lactate. J Neurophysiol. 2008;100(3):1184-201. doi:10.1152/jn.01344.2007
[88] Taylor JL, Amann M, Duchateau J, et al. Neural Contributions to Muscle Fatigue. Med Sci Sports Exerc. 2016;48(11):2294-306. doi:10.1249/MSS.0000000000000923
[89] Li J, King NC, Sinoway LI. ATP concentrations and muscle tension increase linearly with muscle contraction. J Appl Physiol (1985). 2003;95(2):577-83. doi:10.1152/japplphysiol.00185.2003
[90] Olofsson PS, Levine YA, Caravaca A. Single-Pulse Electrical Activation of the Cervical Vagus Nerve Reduces Tumor Necrosis Factor. Bioelectron Med. 2015;2:37-42. doi:10.15424/bioelectronmed.2015.00006
[91] Olofsson PS, Rosas-Ballina M, Levine YA, Tracey KJ. Rethinking inflammation. Immunol Rev. 2012;248(1):188-204. doi:10.1111/j.1600-065X.2012.01138.x
[92] Pavlov VA, Chavan SS, Tracey KJ. Molecular and Functional Neuroscience in Immunity. Annu Rev Immunol. 2018;36:783-812. doi:10.1146/annurev-immunol-042617-053158
[93] Rosas-Ballina M, Olofsson PS, Ochani M, et al. Acetylcholine-synthesizing T cells relay neural signals. Science. 2011;334(6052):98-101. doi:10.1126/science.1209985
[94] Caravaca AS, Gallina AL, Tarnawski L, et al. An Effective Method for Acute Vagus Nerve Stimulation. Front Neurosci. 2019;13:877. doi:10.3389/fnins.2019.00877
[95] Chavan SS, Pavlov VA, Tracey KJ. Mechanisms and Therapeutic Relevance of Neuro-immune Communication. Immunity. 2017;46(6):927-42. doi:10.1016/j.immuni.2017.06.008
[96] Tracey KJ. Hacking the inflammatory reflex. Lancet Neurol. 2021;3:237-9. doi:10.1016/s2665-9913(20)30448-3
[97] Pavlov VA, Tracey KJ. The vagus nerve and the inflammatory reflex. Nat Rev Endocrinol. 2012;8(12):743-54. doi:10.1038/nrendo.2012.189
[98] Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, et al. The vagus nerve: a tonic inhibitory influence. Gastroenterology. 2006;131(4):1122-30. doi:10.1053/j.gastro.2006.08.016
[99] Inoue T, Abe C, Sung SS, et al. Vagus nerve stimulation mediates protection from kidney ischemia-reperfusion injury. J Clin Invest. 2016;126(5):1939-52. doi:10.1172/JCI83658
[100] Lai Y, Deng J, Wang M, et al. Vagus nerve stimulation protects against acute liver injury. Biomed Pharmacother. 2019;117:109062. doi:10.1016/j.biopha.2019.109062
[101] Zhang Y, Li H, Wang M, et al. Vagus Nerve Stimulation Attenuates Acute Skeletal Muscle Injury. Oxid Med Cell Longev. 2019;2019:9208949. doi:10.1155/2019/9208949
[102] Xin Y, Zhang Y, Deng S, Hu X. Vagus Nerve Stimulation Attenuates Acute Skeletal Muscle Injury. Front Pharmacol. 2022;12:756997. doi:10.3389/fphar.2021.756997
[103] Knight CM, Gutierrez-Juarez R, Lam TK, et al. Mediobasal hypothalamic SIRT1 is essential for resveratrol’s effects on insulin action. Diabetes. 2011;60(11):2691-700. doi:10.2337/db10-0987
[104] Ugwu FN, Yu AP, Sin TK, et al. Protective Effect of Unacylated Ghrelin on Compression-Induced Skeletal Muscle Injury. Front Physiol. 2017;8:962. doi:10.3389/fphys.2017.00962
[105] Jude JA, Wylam ME, Walseth TF, Kannan MS. Calcium signaling in airway smooth muscle. Proc Am Thorac Soc. 2008;5(1):15-22. doi:10.1513/pats.200704-047VS
[106] Lynch K, Fernandez G, Pappalardo A, Peluso JJ. Basic fibroblast growth factor inhibits apoptosis. Endocrinology. 2000;141(11):4209-17. doi:10.1210/endo.141.11.7742
[107] Berridge MJ, Lipp P, Bootman MD. The versatility and universality of calcium signalling. Nat Rev Mol Cell Biol. 2000;1(1):11-21. doi:10.1038/35036035
[108] Lee HC, Walseth TF, Bratt GT, et al. Structural determination of a cyclic metabolite of NAD+. J Biol Chem. 1989;264(3):1608-15. PMID:2912976
[109] Ernst IM, Fliegert R, Guse AH. Adenine Dinucleotide Second Messengers. Front Immunol. 2013;4:259. doi:10.3389/fimmu.2013.00259
[110] Galione A, Parrington J, Funnell T. Physiological roles of NAADP-mediated Ca2+ signaling. Sci China Life Sci. 2011;54(8):725-32. doi:10.1007/s11427-011-4207-5
[111] Clapper DL, Lee HC. Inositol Trisphosphate Induces Calcium Release. J Biol Chem. 1985;260(26):13947-54. doi:10.1016/S0021-9258(17)38668-4
[112] Lee HC, Aarhus R. A derivative of NADP mobilizes calcium stores. J Biol Chem. 1995;270(5):2152-7. doi:10.1074/jbc.270.5.2152
[113] Churchill GC, Okada Y, Thomas JM, et al. NAADP mobilizes Ca(2+) from reserve granules. Cell. 2002;111(5):703-8. doi:10.1016/s0092-8674(02)01082-6
[114] Calcraft PJ, Ruas M, Pan Z, et al. NAADP mobilizes calcium from acidic organelles. Nature. 2009;459(7246):596-600. doi:10.1038/nature08030
[115] Aley PK, Singh N, Brailoiu GC, et al. Nicotinic acid adenine dinucleotide phosphate is a second messenger. J Biol Chem. 2013;288(16):10986-93. doi:10.1074/jbc.M113.458620
[116] Walseth TF, Guse AH. NAADP: From Discovery to Mechanism. Front Immunol. 2021;12:703326. doi:10.3389/fimmu.2021.703326
[117] Lee HC. Enzymatic functions and structures of CD38 and homologs. Chem Immunol. 2000;75:39-59. doi:10.1159/000058774
[118] White TA, Johnson S, Walseth TF, et al. Subcellular localization of cyclic ADP-ribosyl cyclase. Biochim Biophys Acta. 2000;1498(1):64-71. doi:10.1016/s0167-4889(00)00077-x
[119] Zhao YJ, Lam CM, Lee HC. The membrane-bound enzyme CD38 exists in two opposing orientations. Sci Signal. 2012;5(241):ra67. doi:10.1126/scisignal.2002700
[120] Liu J, Zhao YJ, Li WH, et al. Cytosolic interaction of type III human CD38 with CIB1. Proc Natl Acad Sci USA. 2017;114(31):8283-8. doi:10.1073/pnas.1703718114
[121] Lin WK, Bolton EL, Cortopassi WA, et al. Synthesis of the Ca2+-mobilizing messengers NAADP and cADPR. J Biol Chem. 2017;292(32):13243-57. doi:10.1074/jbc.M117.789347
[122] Lee HC. Structure and enzymatic functions of human CD38. Mol Med. 2006;12(11-12):317-23. doi:10.2119/2006-00086.Lee
[123] Camacho-Pereira J, Tarragó MG, Chini CCS, et al. CD38 Dictates Age-Related NAD Decline. Cell Metab. 2016;23(6):1127-39. doi:10.1016/j.cmet.2016.05.006
[124] Wang LF, Huang CC, Xiao YF, et al. CD38 Deficiency Protects Heart from High Fat Diet-Induced Oxidative Stress. Cell Physiol Biochem. 2018;48(6):2350-63. doi:10.1159/000492651
[125] Tirumurugaan KG, Jude JA, Kang BN, et al. TNF-alpha induced CD38 expression in human airway smooth muscle cells. Am J Physiol Lung Cell Mol Physiol. 2007;292(6):L1385-95. doi:10.1152/ajplung.00472.2006
[126] Deshpande DA, Walseth TF, Panettieri RA, Kannan MS. CD38/cyclic ADP-ribose-mediated Ca2+ signaling. FASEB J. 2003;17(3):452-4. doi:10.1096/fj.02-0450fje
[127] Deshpande DA, Dogan S, Walseth TF, et al. Modulation of calcium signaling by interleukin-13. Am J Respir Cell Mol Biol. 2004;31(1):36-42. doi:10.1165/rcmb.2003-0313OC
[128] Han Y, Weinman S, Boldogh I, et al. Tumor necrosis factor-alpha-inducible IkappaBalpha proteolysis. J Biol Chem. 1999;274:787-94. doi:10.1074/jbc.274.2.787
[129] Iguchi-Hashimoto M, Usui T, Yoshifuji H, et al. Overexpression of a minimal domain of calpastatin suppresses IL-6 production. PLoS One. 2011;6:e27020. doi:10.1371/journal.pone.0027020
[130] Kishimoto A, Mikawa K, Hashimoto K, et al. Limited proteolysis of protein kinase C subspecies by calpain. J Biol Chem. 1989;264(7):4088-92. PMID:2537303
[131] Smuder AJ, Kavazis AN, Hudson MB, et al. Oxidation enhances myofibrillar protein degradation. Free Radic Biol Med. 2010;49(7):1152-60. doi:10.1016/j.freeradbiomed.2010.06.025
[132] Nakagawa T, Yuan J. Cross-talk between two cysteine protease families. J Cell Biol. 2000;150(4):887-94. doi:10.1083/jcb.150.4.887
[133] Mandic A, Viktorsson K, Strandberg L, et al. Calpain-mediated Bid cleavage and calpain-independent Bak modulation. Mol Cell Biol. 2002;22(9):3003-13. doi:10.1128/MCB.22.9.3003-3013.2002
[134] Kobayashi S, Yamashita K, Takeoka T, et al. Calpain-mediated X-linked inhibitor of apoptosis degradation. J Biol Chem. 2002;277(37):33968-77. doi:10.1074/jbc.M203350200
[135] Bernardi P, Petronilli V, Di Lisa F, Forte M. A mitochondrial perspective on cell death. Trends Biochem Sci. 2001;26(2):112-7. doi:10.1016/s0968-0004(00)01745-x
[136] Todt F, Cakir Z, Reichenbach F, et al. Differential retrotranslocation of mitochondrial Bax and Bak. EMBO J. 2015;34(1):67-80. doi:10.15252/embj.201488806
[137] Guo BS, Cheung KK, Yeung SS, et al. Electrical stimulation influences satellite cell proliferation and apoptosis. PLoS One. 2012;7(1):e30348. doi:10.1371/journal.pone.0030348
[138] Garrido C, Galluzzi L, Brunet M, et al. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ. 2006;13(9):1423-33. doi:10.1038/sj.cdd.4401950
[139] Polster BM, Basañez G, Etxebarria A, Hardwick JM, Nicholls DG. Calpain I induces cleavage and release of apoptosis-inducing factor from isolated mitochondria. J Biol Chem. 2005;280(8):6447-54. doi:10.1074/jbc.M413269200
[140] Cregan SP, Dawson VL, Slack RS. Role of AIF in caspase-dependent and caspase-independent cell death. Oncogene. 2004;23(16):2785-96. doi:10.1038/sj.onc.1207517
[141] Cerqueira É, Marinho DA, Neiva HP, Lourenço O. Inflammatory Effects of High and Moderate Intensity Exercise-A Systematic Review. Front Physiol. 2020;10:1550. doi:10.3389/fphys.2019.01550
[142] Di Felice V, Coletti D, Seelaender M. Editorial: Myokines, Adipokines, Cytokines in Muscle Pathophysiology, Volume II. Front Physiol. 2022;13:907956. doi:10.3389/fphys.2022.907956
[143] Pedersen BK, Steensberg A, Fischer C, Keller C, Keller P, Plomgaard P, Febbraio M, Saltin B. Searching for the exercise factor: is IL-6 a candidate? J Muscle Res Cell Motil. 2003;24(2-3):113-9. doi:10.1023/a:1026070911202
[144] Pedersen BK, Akerström TC, Nielsen AR, Fischer CP. Role of myokines in exercise and metabolism. J Appl Physiol (1985). 2007;103(3):1093-8. doi:10.1152/japplphysiol.00080.2007
[145] Lee JH, Jun HS. Role of Myokines in Regulating Skeletal Muscle Mass and Function. Front Physiol. 2019;10:42. doi:10.3389/fphys.2019.0004
[146] Fernandez-Real JM, Vayreda M, Richart C, Gutierrez C, Broch M, Vendrell J, et al. Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women. J Clin Endocrinol Metab. 2001;86(3):1154-9. doi:10.1210/jcem.86.3.7305
[147] Garneau L, Parsons SA, Smith SR, Mulvihill EE, Sparks LM, Aguer C. Plasma Myokine Concentrations After Acute Exercise in Non-obese and Obese Sedentary Women. Front Physiol. 2020;11:18. doi:10.3389/fphys.2020.00018
[148] Rosendal L, Søgaard K, Kjaer M, Sjøgaard G, Langberg H, Kristiansen J. Increase in interstitial interleukin-6 of human skeletal muscle with repetitive low-force exercise. J Appl Physiol (1985). 2005;98(2):477-81. doi:10.1152/japplphysiol.00130.2004
[149] Steensberg A, van Hall G, Osada T, Sacchetti M, Saltin B, Klarlund Pedersen B. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol. 2000;529(Pt1):237-42. doi:10.1111/j.1469-7793.2000.00237.x
[150] VanderVeen BN, Fix DK, Montalvo RN, Counts BR, Smuder AJ, Murphy EA, Koh HJ, Carson JA. The regulation of skeletal muscle fatigability and mitochondrial function by chronically elevated interleukin-6. Exp Physiol. 2019;104(3):385-397. doi:10.1113/EP087429
[151] Nielsen AR, Pedersen BK. The biological roles of exercise-induced cytokines: IL-6, IL-8, and IL-15. Appl Physiol Nutr Metab. 2007 Oct;32(5):833-9. doi:10.1139/H07-054
[152] Muñoz-Cánoves P, Scheele C, Pedersen BK, Serrano AL. Interleukin-6 myokine signaling in skeletal muscle: a double-edged sword? FEBS J. 2013;280(17):4131-48. doi:10.1111/febs.12338
[153] Nara H, Watanabe R. Anti-Inflammatory Effect of Muscle-Derived Interleukin-6 and Its Involvement in Lipid Metabolism. Int J Mol Sci. 2021;22(18):9889. doi:10.3390/ijms22189889
[154] Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood. 1990;75(1):40-7. PMID: 2294996
[155] Matthys P, Mitera T, Heremans H, Van Damme J, Billiau A. Anti-gamma interferon and anti-interleukin-6 antibodies affect staphylococcal enterotoxin B-induced weight loss, hypoglycemia, and cytokine release in D-galactosamine-sensitized and unsensitized mice. Infect Immun. 1995;63(4):1158-64. doi:10.1128/iai.63.4.1158-1164.1995
[156] Starkie R, Ostrowski SR, Jauffred S, Febbraio M, Pedersen BK. Exercise and IL-6 infusion inhibit endotoxin-induced TNF-alpha production in humans. FASEB J. 2003;17(8):884-6. doi:10.1096/fj.02-0670fje
[157] Gleeson M. Immune system adaptation in elite athletes. Curr Opin Clin Nutr Metab Care. 2006;9(6):659-65. doi:10.1097/01.mco.0000247476.02650.18
[158] Docherty S, Harley R, McAuley JJ, Crowe LAN, Pedret C, Kirwan PD, Siebert S, Millar NL. The effect of exercise on cytokines: implications for musculoskeletal health: a narrative review. BMC Sports Sci Med Rehabil. 2022;14(1):5. doi:10.1186/s13102-022-00397-2
[159] Chesrown SE, Monnier J, Visner G, Nick HS. Regulation of inducible nitric oxide synthase mRNA levels by LPS, INF-gamma, TGF-beta, and IL-10 in murine macrophage cell lines and rat peritoneal macrophages. Biochem Biophys Res Commun. 1994;200(1):126-34. doi:10.1006/bbrc.1994.1424
[160] Dobbs RJ, Charlett A, Purkiss AG, Dobbs SM, Weller C, Peterson DW. Association of circulating TNF-alpha and IL-6 with ageing and parkinsonism. Acta Neurol Scand. 1999;100(1):34-41. doi:10.1111/j.1600-0404.1999.tb00721.x
[161] Hirata A, Masuda S, Tamura T, Kai K, Ojima K, Fukase A, et al. Expression profiling of cytokines and related genes in regenerating skeletal muscle after cardiotoxin injection: a role for osteopontin. Am J Pathol. 2003;163(1):203-15. doi:10.1016/S0002-9440(10)63644-9
[162] Kojouharov HV, Chen-Charpentier BM, Solis FJ, Biguetti C, Brotto M. A simple model of immune and muscle cell crosstalk during muscle regeneration. Math Biosci. 2021;333:108543. doi:10.1016/j.mbs.2021.108543
[163] de Oliveira AK, Pramoonjago P, Rucavado A, Moskaluk C, Silva DT, Escalante T, Gutiérrez JM, Fox JW. Mapping the Immune Cell Microenvironment with Spatial Profiling in Muscle Tissue Injected with the Venom of Daboia russelii. Toxins (Basel). 2023;15(3):208. doi:10.3390/toxins15030208
[164] Shinozaki S, Chang K, Sakai M, Shimizu N, Yamada M, Tanaka T, et al. Inflammatory stimuli induce inhibitory S-nitrosylation of the deacetylase SIRT1 to increase acetylation and activation of p53 and p65. Sci Signal. 2014;7(351):ra106. doi:10.1126/scisignal.2005375
[165] Li H, Malhotra S, Kumar A. Nuclear factor-kappa B signaling in skeletal muscle atrophy. J Mol Med (Berl). 2008;86(10):1113-26. doi:10.1007/s00109-008-0373-8
[166] Fox DK, Ebert SM, Bongers KS, Dyle MC, Bullard SA, Dierdorff JM, Kunkel SD, Adams CM. p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization. Am J Physiol Endocrinol Metab. 2014;307(3):E245-61. doi:10.1152/ajpendo.00010.2014
[167] Hall DT, Ma JF, Marco SD, Gallouzi IE. Inducible nitric oxide synthase (iNOS) in muscle wasting syndrome, sarcopenia, and cachexia. Aging (Albany NY). 2011;3(8):702-15. doi:10.18632/aging.100358
[168] Hall DT, Griss T, Ma JF, Sanchez BJ, Sadek J, Tremblay AMK, Mubaid S, Omer A, Ford RJ, Bedard N, Pause A, Wing SS, Di Marco S, Steinberg GR, Jones RG, Gallouzi IE. The AMPK agonist 5-aminoimidazole-4-carboxamide ribonucleotide (AICAR), but not metformin, prevents inflammation-associated cachectic muscle wasting. EMBO Mol Med. 2018;10(7):e8307. doi:10.15252/emmm.20170830
[169] Di Marco S, Cammas A, Lian XJ, Kovacs EN, Ma JF, Hall DT, et al. The translation inhibitor pateamine A prevents cachexia-induced muscle wasting in mice. Nat Commun. 2012;3:896. doi:10.1038/ncomms1899
[170] Ma JF, Sanchez BJ, Hall DT, Tremblay AK, Di Marco S, Gallouzi IE. STAT3 promotes IFNγ/TNFα-induced muscle wasting in an NF-κB-dependent and IL-6-independent manner. EMBO Mol Med. 2017;9(5):622-637. doi:10.15252/emmm.201607052
[171] Buck M, Chojkier M. Muscle wasting and dedifferentiation induced by oxidative stress in a murine model of cachexia is prevented by inhibitors of nitric oxide synthesis and antioxidants. EMBO J. 1996;15(8):1753-65. PMID: 8617220
[172] Nakazawa H, Chang K, Shinozaki S, Yasukawa T, Ishimaru K, Yasuhara S, et al. iNOS as a Driver of Inflammation and Apoptosis in Mouse Skeletal Muscle after Burn Injury: Possible Involvement of Sirt1 S-Nitrosylation-Mediated Acetylation of p65 NF-κB and p53. PLoS One. 2017;12(1):e0170391. doi:10.1371/journal.pone.0170391
[173] Zhang W, Huang Q, Zeng Z, Wu J, Zhang Y, Chen Z. Sirt1 Inhibits Oxidative Stress in Vascular Endothelial Cells. Oxid Med Cell Longev. 2017;2017:7543973. doi:10.1155/2017/7543973
[174] Judge AR, Koncarevic A, Hunter RB, Liou HC, Jackman RW, Kandarian SC. Role for IkappaBalpha, but not c-Rel, in skeletal muscle atrophy. Am J Physiol Cell Physiol. 2007;292(1):C372-82. doi:10.1152/ajpcell.00293.2006
[175] Yang H, Zhang W, Pan H, Feldser HG, Lainez E, Miller C, et al. SIRT1 activators suppress inflammatory responses through promotion of p65 deacetylation and inhibition of NF-κB activity. PLoS One. 2012;7(9):e46364. doi:10.1371/journal.pone.0046364
[176] Chen J, Zhou Y, Mueller-Steiner S, Chen LF, Kwon H, Yi S, et al. SIRT1 protects against microglia-dependent amyloid-beta toxicity through inhibiting NF-kappaB signaling. J Biol Chem. 2005;280(48):40364–74. doi:10.1074/jbc.M509329200
[177] Bellinger AM, Reiken S, Carlson C, Mongillo M, Liu X, Rothman L, et al. Hypernitrosylated ryanodine receptor calcium release channels are leaky in dystrophic muscle. Nat Med. 2009;15(3):325-30. doi:10.1038/nm.1916
[178] Sun J, Xin C, Eu JP, Stamler JS, Meissner G. Cysteine-3635 is responsible for skeletal muscle ryanodine receptor modulation by NO. Proc Natl Acad Sci USA. 2001;98(20):11158-62. doi:10.1073/pnas.201289098
[179] McCafferty DM, Mudgett JS, Swain MG, Kubes P. Inducible nitric oxide synthase plays a critical role in resolving intestinal inflammation. Gastroenterology. 1997;112(3):1022-7. doi:10.1053/gast.1997.v112.pm9041266
[180] Rigamonti E, Touvier T, Clementi E, Manfredi AA, Brunelli S, Rovere-Querini P. Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage. J Immunol. 2013;190(4):1767-77. doi:10.4049/jimmunol.1202903
[181] Rovere-Querini P, Clementi E, Brunelli S. Nitric oxide and muscle repair: multiple actions converging on therapeutic efficacy. Eur J Pharmacol. 2014;730:181-5. doi:10.1016/j.ejphar.2013.11.006
Functional and Metabolic Muscle Responses to Exercise
How to cite this paper: Dmitriy V. Muzhenya, Sergey P. Lysenkov. (2025) Functional and Metabolic Muscle Responses to Exercise. Health and Prevention Journal, 2(1), 1-18.
DOI: http://dx.doi.org/10.26855/hpj.2025.12.001